| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Wednesday, March 27, 2024 3:11:50 AM
The laws are there. But, there is something called free speech. And absent intrusive state surveillance if all of your personal communications, they do not and can early catch even the most blatant fraudsters. I do not believe Adam exchanges info for trading advantage but for journalistic advantage. And THAT is extremely difficult if not impossible to charge as he is entitled to write opinion, and they say it is “opinion”. Then the problem is, he has a following, and it’s a following that knows the bigger shorts are likely driving his columns and they join in the shorting. Everyone literally knows what is going on, but there is little they can do.
I think unfortunately, the only way to deal with that is to regulate shorting of small stocks, stocks that are in small imperfect markets like these tiny biotechs. You should only be able to short against actually held shares, to protect one’s holdings only. Portfolio insurance. You should actually hold shares when you short and the amounts should not be more shares than exist in the marketplace. I believe that would change the dynamic immensely in this space.
And maybe during certain times, there should be no shorting allowed. You’re either in or you’re out, period.
There is a value to shorting. But it has become a tool for market manipulation by big players in small markets and the regulators and members of Congress either do not understand or are in the pockets of these big funds and have reason not to understand. In either case, shorting needs to be regulated. I do not see regulation of “journalistic” free speech or greater surveillance as likely.
I think unfortunately, the only way to deal with that is to regulate shorting of small stocks, stocks that are in small imperfect markets like these tiny biotechs. You should only be able to short against actually held shares, to protect one’s holdings only. Portfolio insurance. You should actually hold shares when you short and the amounts should not be more shares than exist in the marketplace. I believe that would change the dynamic immensely in this space.
And maybe during certain times, there should be no shorting allowed. You’re either in or you’re out, period.
There is a value to shorting. But it has become a tool for market manipulation by big players in small markets and the regulators and members of Congress either do not understand or are in the pockets of these big funds and have reason not to understand. In either case, shorting needs to be regulated. I do not see regulation of “journalistic” free speech or greater surveillance as likely.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
